These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 35813258

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
    Alberts AR, Roobol MJ, Verbeek JFM, Schoots IG, Chiu PK, Osses DF, Tijsterman JD, Beerlage HP, Mannaerts CK, Schimmöller L, Albers P, Arsov C.
    Eur Urol; 2019 Feb; 75(2):310-318. PubMed ID: 30082150
    [Abstract] [Full Text] [Related]

  • 5. Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients?
    Falagario UG, Silecchia G, Bruno SM, Di Nauta M, Auciello M, Sanguedolce F, Milillo P, Macarini L, Selvaggio O, Carrieri G, Cormio L.
    Front Oncol; 2020 Feb; 10():603384. PubMed ID: 33489907
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical Utility of Negative Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer and Clinically Significant Prostate Cancer.
    Wagaskar VG, Levy M, Ratnani P, Moody K, Garcia M, Pedraza AM, Parekh S, Pandav K, Shukla B, Prasad S, Sobotka S, Haines K, Punnen S, Wiklund P, Tewari A.
    Eur Urol Open Sci; 2021 Jun; 28():9-16. PubMed ID: 34337520
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and European men.
    Chen R, Verbeek JFM, Yang Y, Song Z, Sun Y, Roobol MJ.
    World J Urol; 2021 Jan; 39(1):73-80. PubMed ID: 32279141
    [Abstract] [Full Text] [Related]

  • 12. The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men.
    Vedder MM, de Bekker-Grob EW, Lilja HG, Vickers AJ, van Leenders GJ, Steyerberg EW, Roobol MJ.
    Eur Urol; 2014 Dec; 66(6):1109-15. PubMed ID: 25168616
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multi-institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI-RADS 3 lesions.
    Fang AM, Shumaker LA, Martin KD, Jackson JC, Fan RE, Khajir G, Patel HD, Soodana-Prakash N, Vourganti S, Filson CP, Sonn GA, Sprenkle PC, Gupta GN, Punnen S, Rais-Bahrami S.
    Cancer; 2022 Sep 15; 128(18):3287-3296. PubMed ID: 35819253
    [Abstract] [Full Text] [Related]

  • 15.
    Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J.
    ; 2018 05 15. PubMed ID: 30085502
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enhancement of prostate cancer diagnosis by machine learning techniques: an algorithm development and validation study.
    Chiu PK, Shen X, Wang G, Ho CL, Leung CH, Ng CF, Choi KS, Teoh JY.
    Prostate Cancer Prostatic Dis; 2022 Apr 15; 25(4):672-676. PubMed ID: 34267331
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. External validation of two mpMRI-risk calculators predicting risk of prostate cancer before biopsy.
    Pallauf M, Steinkohl F, Zimmermann G, Horetzky M, Rajwa P, Pradere B, Lindner AK, Pichler R, Kunit T, Shariat SF, Lusuardi L, Drerup M.
    World J Urol; 2022 Oct 15; 40(10):2451-2457. PubMed ID: 35941246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.